Voloridge Investment Management
ALXO icon

Voloridge Investment Management’s ALX Oncology ALXO Stock Holding History

Voloridge Investment Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-46,070
Closed -$441K – 1415
2022
Q3 		$441K Sell
46,070
-90,758
-66% -$1.06M ﹤0.01% 1283
2022
Q2 		$1.11M Sell
136,828
-76,009
-36% -$828K 0.01% 1159
2022
Q1 		$3.6M Buy
212,837
+46,775
+28% +$799K 0.02% 754
2021
Q4 		$3.57M Buy
+166,062
New +$7.16M 0.02% 844
2021
Q3 		– Sell
-59,891
Closed -$3.27M – 1621
2021
Q2 		$3.27M Buy
59,891
+52,109
+670% +$3.12M 0.02% 797
2021
Q1 		$574K Buy
+7,782
New +$612K ﹤0.01% 1154

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Voloridge Investment Management's ALXO Position: Q4 2022 in Review

Voloridge Investment Management sold out of ALX Oncology (ALXO) in Q4 2022, closing a stake of 46,070 shares — an estimated $441K sold.

Voloridge Investment Management first reported a position in ALXO in Q1 2021 and held it in 6 quarters. The position peaked at $3.6M in Q1 2022. 87 funds tracked by Wall St. Rank hold ALXO as of Q4 2022.

  • Voloridge Investment Management reported no remaining ALX Oncology position as of Q4 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 46,070 ALX Oncology shares in Q4 2022, an estimated $441K.
  • Voloridge Investment Management first reported a position in ALX Oncology in Q1 2021 and held it in 6 quarters.
  • Voloridge Investment Management's ALX Oncology position peaked at $3.6M in Q1 2022.
  • 87 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2022.

Based on Voloridge Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.